Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Gilead, Kite buy Cell Design Labs

Executive Summary

Just four months after thrusting itself into the cell therapy space through the $11.9bn acquisition of Kite Pharma Inc., Gilead Sciences Inc. is acquiring privately held Cell Design Labs Inc., another player in the engineered cellular therapeutics market.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Intra-Biotech Deal
    • Includes Earnout
    • Full Acquisition
    • Payment Includes Cash

Related Companies

UsernamePublicRestriction

Register